about
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancerSirtuins and Cancer: Role in the Epithelial-Mesenchymal TransitionObesity and colorectal cancer: role of adipokines in tumor initiation and progressionAssociation between Birt Hogg Dube syndrome and cancer predisposition.Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraine.Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms studyType 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant StressParallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.Analysis of adenomatous polyposis coli gene in thyroid tumoursO039. Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele PisanaMicrosatellite instability in thyroid tumours and tumour-like lesions.Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy.Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.Non-steroidal anti-inflammatory drugs in cancer prevention and therapy.Age-related reduction of cerebral ischemic preconditioning: myth or reality?Role of genetic polymorphisms of ion channels in the pathophysiology of coronary microvascular dysfunction and ischemic heart disease.Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention.Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments.Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial.Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related Diseases.Ovarian cancer: Novel molecular aspects for clinical assessment.Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle.Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA)ALK gene alterations in cancer: biological aspects and therapeutic implications.Sex-Genetic Interaction in the Risk for Cerebrovascular Disease.The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators.Serotonin receptor targeted therapy for migraine treatment: an overview of drugs in phase I and II clinical development.A reliable and reproducible technique for DNA fingerprinting in biorepositories: a pilot study from BioBIM.Desmoid Tumors in Familial Adenomatous Polyposis.RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank.Preanalytical Procedures for DNA Studies: The Experience of the Interinstitutional Multidisciplinary BioBank (BioBIM).Determinants of homocysteine levels in colorectal and breast cancer patients.Red meat, family history, and increased risk of gastric cancer with microsatellite instability.Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management.Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer.
P50
Q24324198-B9BAE8FA-2095-4B38-BD6D-36E6571748CFQ26744502-59C5C8BD-5FED-4DF1-9BB8-AF73313E846BQ26853740-9DA8C3B1-EC41-4E31-830A-8286807D1EEBQ34110195-9DC1E1FA-9118-4408-A7DE-866A6E54BC6CQ34811435-86BF160D-D5F2-4950-8547-1CC618C6A8A4Q35039274-FD984777-FC4F-4518-B1FB-5A0CFFA399CDQ35110747-95ECF115-BBF1-476B-95DC-C669B31758BDQ35638065-A5FF505B-BF8B-41AC-BB60-940347510061Q35782187-FC22BBA7-C98D-40FA-9A78-C4ECC1ED602BQ35921190-1F8EDE4F-B51F-49B6-BA28-DCC9A133D585Q36080630-6C48DAA5-F42E-4347-A85A-BD466DBA6C2DQ36468539-DB495C0D-5025-45B1-AF1E-E8D2C055074FQ36617401-2B311F46-68C1-4685-AE3F-CF4875017344Q36792803-898FC821-E936-4C84-A5A9-260AE14ABDF2Q36919780-32FBAE17-C746-498B-BC49-68FEED7C1D91Q36985567-DA94C51F-0216-48ED-A2A8-9DC2A7EE7D11Q37278544-B022ECD1-F0E9-4361-A02E-D9507B79C6E9Q37501931-459D66C1-D002-4F1E-ACEC-15CF3AB88EB4Q37877245-250159BE-347D-4BF9-98AF-8AAF00EAA0AAQ37998525-015483E1-8479-4008-90D7-34C65F340DFDQ38023747-37BDF3AA-4BBB-4A1A-98ED-9F94DD607E1CQ38061499-BFA6E77B-3472-40B5-B3CE-CD4E0D26BD1EQ38307997-E76DF00C-737C-4E28-8918-D926217A518FQ38462843-DC5EB36C-3DBA-4B5D-B5DD-B5EEE4BAA1D8Q38564821-404FED58-9F43-431E-AF72-2C88B58C89D7Q38625393-B48BE882-1623-424E-B1CC-065A3FCDC65FQ38626800-94C0917E-6BEE-4047-9D55-D7C9B6C0A8FCQ38705941-0E986EFE-D208-46ED-91BD-9BC4CE5DD94EQ38767006-6D4426F2-A703-4DEA-A6E3-0F4146EB012AQ38834779-6FAF9357-1165-4EE0-9668-1F2660B44EA4Q38909440-51ABF099-C555-478A-B136-4F9E1699023FQ39012465-DD3737E6-6FA0-4CFF-8BFB-09005D429EEDQ39380583-ACEFC99E-0FDE-4869-9404-6E4436AA8BDAQ39409180-803D69AD-2CF2-46ED-B0BB-6D9826D40492Q39749956-057755B2-0BA4-485D-90AD-5ECE4D3276D6Q39778725-C75DE9D0-B450-4D48-BD1B-B55A3AFA7CE8Q43257168-3A48AB26-20C2-4BC5-8CF5-395E7A96AA57Q43675296-6035DF96-D813-4C5F-9F17-4E6DBAC61C75Q45026631-A3AD9422-DB3E-46A9-80DE-FAC5ACBE31D4Q45983375-A3E96AB5-1139-46E7-A260-C0ADD90EF5F1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Raffaele Palmirotta
@ast
Raffaele Palmirotta
@en
Raffaele Palmirotta
@es
Raffaele Palmirotta
@nl
type
label
Raffaele Palmirotta
@ast
Raffaele Palmirotta
@en
Raffaele Palmirotta
@es
Raffaele Palmirotta
@nl
prefLabel
Raffaele Palmirotta
@ast
Raffaele Palmirotta
@en
Raffaele Palmirotta
@es
Raffaele Palmirotta
@nl
P106
P1153
6602152137
P21
P31
P496
0000-0002-9401-7377